Piper Sandler raised the firm’s price target on Solventum (SOLV) to $94 from $87 and keeps an Overweight rating on the shares. The firm notes the company reported Q2 results that included revenue of $2,161M/+2.8% organic and EPS of $1.69, another strong quarter of performance vs. consensus and consistent with its preview call, with the ever-growing execution track record one of the key characteristics that drew us to upgrade the stock a couple months ago.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLV:
- Solventum Corporation Reports Strong Q2 2025 Results
- Solventum raises FY25 adjusted EPS view to $5.80-$5.95 from $5.45-$5.65
- Solventum reports Q2 adjusted EPS $1.69, consensus $1.45
- DoorDash, Southwest downgraded: Wall Street’s top analyst calls
- Solventum upgraded to Overweight from Equal Weight at Morgan Stanley